The Union Health Ministry of India has approved Corbevax as a heterologous COVID-19 booster dose under emergency use authorization for individuals aged 18 years.
In section 45ZL of the Reserve Bank of India Act, 1934, the Reserve Bank publishes the minutes of the proceedings of the meeting on the fourteenth day after every meeting of the Monetary Policy Committee.